Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients

Bone Marrow Transplantation

Volumn 45, Issue 1, 2010, Pages 129-136

  Ogata, M ^a,b   Satou, T ^b   Kawano, R ^b   Takakura, S ^b   Goto, K ^b   Ikewaki, J ^b   Kohno, K ^b   Ikebe, T ^c   Ando, T ^c   Miyazaki, Y ^c   Ohtsuka, E ^c   Saburi, Y ^c   Saikawa, T ^a   Kadota, J ^b  

^a OITA UNIVERSITY HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

^c OITA PREFECTURAL HOSPITAL   (Japan)

Author keywords

Allo SCT; Central nervous system dysfunction; Cytokines; Encephalitis; Human herpesvirus 6; IL 6

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; FEMALE; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HUMAN HERPESVIRUS 6; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS LOAD;

ADOLESCENT; ADULT; CHILD; DNA, VIRAL; ENCEPHALITIS, VIRAL; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; ROSEOLOVIRUS INFECTIONS; STEM CELL TRANSPLANTATION; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 75149172279     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.116     Document Type: Article

References (33)

1. Yoshikawa T, Asano Y, Ihira M, Suzuki K, Ohashi M, Suga S et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002; 185: 847-853.
2. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 932-940.
3. Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K et al. Human herpesvirus 6 DNA load in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006; 193: 68-79.
4. Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007; 13: 100-106.
5. Zerr DM. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006; 37: 52-56.
6. Zerr DM. Human herpesvirus 6: a clinical update. Herpes 2006; 13: 20-24.
7. Ogata M, Kadota J-I. Human herpesvirus-6 infections and infection-preventative measures in transplant recipients. Future Virol 2008; 3: 567-578.
8. Ljungman P, de la Camara R, Cordonnier C, Einsele H, Engelhard D, Reusser P et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008; 42: 227-240.
9. Yoshikawa T, Ihira M, Suzuki K, Suga S, Iida K, Saito Y et al. Human herpesvirus 6 infection after living related liver transplantation. J Med Virol 2000; 62: 52-59.
10. Ihira M, Yoshikawa T, Suzuki K, Ohashi M, Suga S, Horibe K et al. Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR. Microbiol Immunol 2002; 46: 701-705.
11. Tomoiu A, Flamand L. Biological and clinical advances in human herpesvirus-6 and -7 research. Future Virol 2006; 1: 623-635.
12. Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111: 774-781.
13. Ogata M, Satou T, Kawano R, Goto K, Ikewaki J, Kohno K et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008; 41: 279-285.
14. Fujimaki K, Mori T, Kida A, Tanaka M, Kawai N, Matsushima T et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006; 84: 432-437.
15. Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 705-709. (Pubitemid 46813587)
16. Muta T, Fukuda T, Harada M. Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study. Bone Marrow Transplant 2009; 43: 583-585.
17. Ito Y, Ichiyama T, Kimura H, Shibata M, Ishiwada N, Kuroki H et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza- virus-associated encephalopathy. J Med Virol 1999; 58: 420-425.
18. Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology 2001; 57: 295-299.
19. Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T et al. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis 2003; 188: 690-698.
20. Otake Y, Yamagata T, Morimoto Y, Imi M, Mori M, Aihara T et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev 2007; 29: 117-120.
21. Ichiyama T, Ito Y, Kubota M, Yamazaki T, Nakamura K, Furukawa S. Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain Dev 2008 (e-pub ahead of print).
22. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
23. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
24. Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV-6. Neurology 2007; 69: 156-165.
25. Thomas ED, Storb R, Clift RA, Fefer A, Jhonson L, Neiman PE et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895-902.
26. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356-1360.
27. Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50: 612-619.
28. Fotheringham J, Akhyani N, Vortmeyer A, Donati D, Williams E, Oh U et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 2007; 195: 450-454.
29. Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, Fujimori Y et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419-426.
30. Nunoi H, Mercado MR, Mizukami T, Okajima K, Morishima T, Sakata H et al. Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int 2005; 47: 175-179.
31. Fujita A, Ihira M, Suzuki R, Enomoto Y, Sugiyama H, Sugata K et al. Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients. J Infect 2008; 57: 241-248.
32. Achour A, Boutolleau D, Gautheret-Dejean A, Agut H. Is human herpesvirus-6 DNA in plasma the right marker for active infection? J Infect Dis 2006; 194: 1795-1796.
33. Achour A, Boutolleau D, Slim A, Agut H, Gautheret-Dejean A. Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles. J Clin Virol 2007; 38: 280-285.